Reported Reactions

Devices › Implant, endosseous, root-form

Device brand name · Endosseous dental implant

NobelParallel CC RP 5.0x13mm: medical device reports filed with FDA

2,635 reports name it, 2019–2026. Manufacturer given most often on reports: Nobel Biocare. Product code DZE.

2,635
device reports naming the brand
0% of all MAUDE reports · about 386 a year
524
reports, 12 months to August 2026
400 in the 12 months before
0.6%
classified as malfunction
0.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

FDA's MAUDE database holds 2,635 reports that name the brand "NobelParallel CC RP 5.0x13mm" (endosseous dental implant), received between September 2019 and August 2026; the manufacturer given most often on reports is Nobel Biocare. Spellings of one product vary from report to report.

524 reports arrived in the 12 months to August 2026, up 31% from 400 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (99.4%) and malfunction (0.6%); across all implant, endosseous, root-form reports (product code DZE) death is recorded in 0% and malfunction in 0.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are failure to osseointegrate (57.6%), loss of osseointegration (33.8%) and osseointegration problem (5.4%). The patient problems coded most often are failure of implant, pain and numbness. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

050100Sep 2021: 57Oct 2021: 13Nov 2021: 40Dec 2021: 212022Jan 2022: 17Feb 2022: 21Mar 2022: 19Apr 2022: 21May 2022: 32Jun 2022: 18Jul 2022: 24Aug 2022: 23Sep 2022: 41Oct 2022: 33Nov 2022: 39Dec 2022: 202023Jan 2023: 15Feb 2023: 33Mar 2023: 33Apr 2023: 38May 2023: 76Jun 2023: 46Jul 2023: 24Aug 2023: 34Sep 2023: 25Oct 2023: 28Nov 2023: 51Dec 2023: 502024Jan 2024: 32Feb 2024: 69Mar 2024: 30Apr 2024: 37May 2024: 56Jun 2024: 30Jul 2024: 33Aug 2024: 44Sep 2024: 21Oct 2024: 40Nov 2024: 22Dec 2024: 382025Jan 2025: 48Feb 2025: 22Mar 2025: 36Apr 2025: 0May 2025: 0Jun 2025: 1Jul 2025: 100Aug 2025: 72Sep 2025: 28Oct 2025: 34Nov 2025: 68Dec 2025: 462026Jan 2026: 56Feb 2026: 46Mar 2026: 24Apr 2026: 70May 2026: 36Jun 2026: 48Jul 2026: 28Aug 2026: 40

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

02284552019: 10820192020: 20920202021: 30220212022: 30820222023: 45320232024: 45220242025: 45520252026: 3482026

Event type and report source

Event type, as classified on the report

Death0%0
Injury99.4%2,619
Malfunction0.6%16
Other0%0
Not given0%0

Who filed the report

Manufacturer report56.7%1,493
Voluntary report0%0
User facility report0%0
Distributor report43.3%1,142
Not given0%0

Grey bar: all 3,924,241 reports carrying product code DZE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Failure to osseointegrate1,51957.6%62.8%
Loss of osseointegration89033.8%22.4%
Osseointegration problem1415.4%7.7%
Patient device interaction problem180.7%0.3%
Insufficient device problem information160.6%0.2%
Fracturea broken bone120.5%1.6%
Migrationthe device moved from where it was placed60.2%0.1%
Malposition of device30.1%0.1%
Difficult to insertthe device was hard to insert20.1%0.4%
Material deformation20.1%0.1%
Separation failure20.1%0.1%
Premature separation10%0.1%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Failure of implant1,90972.4%
Painpain, site not specified2459.3%
Numbnessnumbness722.7%
Appropriate clinical signs, symptoms and conditions term/code not available421.6%
Inflammationinflammation130.5%
Implant pain90.3%
Bone fracture(s)80.3%
Abscessa collection of pus70.3%
Fistula70.3%
Foreign body in patientpart of a device left in the patient40.2%
Sinus perforation40.2%
Hypersensitivity/allergic reaction20.1%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureNobelParallel CC RP 5.0x13mmProduct code DZEAll MAUDE reports
Reports2,6353,924,24126,136,888
Share of that pool—0.1%0%
Classified as death, per 1,000 reports009
Classified as injury99.4%99.2%36.2%
Classified as malfunction0.6%0.8%62.3%
Filed by the manufacturer56.7%77.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DZE

BrandReportsLatest 12 monthsClassified as death
Biohorizons Dental Implant58,73200%
BioHorizons Inc.57,02025,5360%
NobelActive Internal RP 4.3x10mm49,0989,5280%
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim45,6509,6770%
NobelParallel CC RP 4.3x10mm44,2699,3180%
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP41,6727,5310%
Unknown Implant39,9671,4540%
NobelReplace CC RP 4.3x10mm35,9468,1660%
NobelReplace CC PMC RP 4.3x10mm34,4478,6900%
NobelActive Internal RP 4.3x11.5mm33,1175,7040%
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim28,6485,6950%
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim26,7248,4810%
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP26,5404,6800%
NobelActive Internal RP 4.3x13mm25,5563,7640%
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim24,7725,9780%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about NobelParallel CC RP 5.0x13mm reports

How many FDA reports name NobelParallel CC RP 5.0x13mm?

2,635 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 524 in the latest 12 months.

What kinds of events are reported?

injury (99.4%) and malfunction (0.6%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

failure to osseointegrate (57.6%), loss of osseointegration (33.8%), osseointegration problem (5.4%), patient device interaction problem (0.7%) and insufficient device problem information (0.6%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (56.7%) and distributor reports (43.3%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that NobelParallel CC RP 5.0x13mm was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.